ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

LUMIFY
Ocular allergy/inflammation
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

LUMIFY OTC

Generic Name and Formulations:
Brimonidine tartrate 0.025%; oph soln; contains benzalkonium chloride.

Company:
Bausch & Lomb Inc.

Therapeutic Use:

RECENT UPDATES

Monograph added.

Indications for LUMIFY:

To relieve redness due to minor eye irritations.

Adults and Children:

<5yrs: consult physician. ≥5yrs: 1 drop in affected eye(s) every 6–8hrs; max 4 times daily.

Warnings/Precautions:

Discontinue if eye pain, vision changes, continued redness or irritation occurs. Reevaluate if condition worsens or persists >3 days. Remove contact lenses before use; may reinsert 10mins later. Pregnancy. Nursing mothers.

Interactions:

Separate administration of other oph drugs by ≥5mins.

Pharmacological Class:

Alpha-2 agonist.

Generic Availability:

NO

How Supplied:

Soln—2.5mL, 7.5mL

Sign Up for Free e-newsletters



CME Focus